M3, Inc. (MTHRY) Stock

About M3, Inc.

M3, Inc., established in Tokyo, Japan, in 2000, and formerly known as So-netM3, Inc. until its rebranding in January 2010, specializes in delivering a broad range of internet-based services, primarily targeting physicians and other healthcare professionals. The company organizes its operations across five distinct reporting divisions: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. M3 manages several key digital platforms. Its flagship, m3.com, serves as an exclusive online portal providing vital information to healthcare practitioners. Through MR-kun, member doctors gain continuous and independent access to information within the m3.com ecosystem. QOL-kun offers members non-medical lifestyle support, while AskDoctors enables the general public to pose health and illness questions, which are then addressed by registered physicians. Internationally, M3 operates MDLinx for medical professionals in the United States and Doctorsnetuk, a platform that provides development services for pharmaceutical companies and hosts drug information databases for France, Germany, and Spain. Additionally, m3com CAREER facilitates career support services for medical and pharmaceutical professionals. Beyond these platforms, M3 engages in a wide array of activities, including the sales and marketing of pharmaceutical products and medical devices. The company is also involved in developing, selling, and supporting electronic medical record systems and medical equipment for healthcare facilities, conducting professional surveys for medical practitioners, and offering online sales and marketing assistance to pharmaceutical firms. Furthermore, M3 provides management support and consulting services to medical institutions, operates home-visit nursing services, supplies human resources solutions for the healthcare sector, and manages clinical research facilities.

M3, Inc. is headquartered in JP.

M3, Inc. (MTHRY) stock trades at $5.47 with a market capitalization of $7.30B. The stock is valued at a price-to-earnings (P/E) ratio of 25.36, price-to-book of 3.02, price-to-sales of 3.49. Over the past 52 weeks the stock has ranged between $3.97 and $8.85, and currently trades 38.2% below its 52-week high. It pays a dividend yielding 1.46%.

On profitability, M3, Inc. generates a return on equity (ROE) of 12.38%, above the typical market average, return on capital employed of 13.05%, an operating margin of 19.95%, a net profit margin of 13.97%.

Official website: corporate.m3.com